Prognostic factors in progressive high-grade glial tumors treated with systemic approach: A single center experience.
Alan O, Telli TA, Tuylu TB, Arikan R, Demircan NC, Ercelep O, Kaya S, Babacan NA, Atasoy BM, Bozkurt S, Bayri Y, Gul D, Ekinci G, Ziyal I, Dane F, Yumuk PF.
Alan O, et al. Among authors: gul d.
J Oncol Pharm Pract. 2021 Mar;27(2):329-339. doi: 10.1177/1078155220920684. Epub 2020 Apr 29.
J Oncol Pharm Pract. 2021.
PMID: 32349641